Fluphenazine Shortage Update: What Patients Need to Know in 2026

If you're having trouble filling your fluphenazine prescription, you're probably wondering: is there an official shortage? Here is a clear-eyed, up-to-date look at fluphenazine's availability status in 2026 and what it means for patients.

Is Fluphenazine in a National Shortage in 2026?

As of 2026, fluphenazine is not listed on the FDA Drug Shortages Database as an active national shortage. The FDA defines a national drug shortage as a situation where supply is not meeting current demand at a nationwide level. However, a drug can be very difficult to find locally without meeting this formal definition.

This is exactly what many fluphenazine patients experience: their pharmacy is out, nearby pharmacies don't routinely stock it, and it feels like a shortage — even without an official FDA designation.

What Has Happened with Fluphenazine's Supply History?

Fluphenazine has seen episodic supply disruptions over the years — particularly for its injectable forms. The drug has a complex history: it was FDA-approved in 1959 as one of the earliest antipsychotics, became a mainstay of psychiatry for decades, and then fell out of favor after second-generation antipsychotics arrived in the 1990s.

As demand declined, so did the number of manufacturers making fluphenazine. The brand names Prolixin and Permitil were both discontinued. Today, only a small number of generic manufacturers — primarily Teva, Sandoz, and other generics companies — produce fluphenazine. When any one of them has a manufacturing delay or discontinuation, it can affect supply across pharmacies nationwide.

Which Fluphenazine Formulations Have the Most Availability Issues?

Not all forms of fluphenazine are equally available. Here's a general breakdown:

Oral tablets (1 mg, 2.5 mg, 5 mg, 10 mg): Generally available. Most large pharmacy chains carry at least one strength, though your specific dose may require ordering.

Oral elixir (2.5 mg/5 mL) and oral concentrate (5 mg/mL): Less commonly stocked; often requires ordering ahead.

Short-acting injectable (2.5 mg/mL): Often limited to hospital and clinic pharmacies; rarely stocked at retail chains.

Fluphenazine decanoate injection (25 mg/mL): The hardest to find at retail; typically requires a specialty pharmacy or clinic pharmacy.

Why Do Individual Pharmacies Run Out Even Without a National Shortage?

This is one of the most confusing aspects of medication availability. A drug can be nationally "available" but still hard to find at your specific pharmacy for these reasons:

Your pharmacy doesn't routinely stock it because prescription volume is low — they order only what's actively needed

Your pharmacy's distributor may have a temporary regional shortage even while other distributors have stock

The specific strength or formulation you need may have a different supply chain than other versions

A recent order by another patient may have depleted a small inventory

What Can Patients Do When They Can't Find Fluphenazine?

Here is a practical action plan:

Ask your current pharmacy to order it — most can have it within 1–2 business days if it's in national supply

Call other pharmacies in your area, including independent pharmacies and hospital outpatient pharmacies

Use medfinder — medfinder calls pharmacies near you to find which ones have your medication available, so you don't have to make all the calls yourself

Contact your prescribing doctor — they may have access to samples or alternative sourcing, or can write for a different formulation temporarily

Never stop taking fluphenazine abruptly — if you're running critically low, contact your doctor immediately

Is Fluphenazine Likely to Experience Future Shortages?

Given its declining prescription volume, small number of manufacturers, and discontinued brand name, fluphenazine is structurally vulnerable to supply disruptions. Any manufacturing hiccup, distributor issue, or raw material delay could trigger a more serious shortage in the future. Patients who rely on fluphenazine — especially those on the decanoate injection — should maintain close communication with their pharmacy and prescriber and plan ahead whenever possible.

The Bottom Line

Fluphenazine is not in a national FDA shortage as of 2026, but localized stocking gaps are a real and ongoing challenge — especially for injectable formulations. If you're struggling to fill your prescription, read our step-by-step guide on how to find fluphenazine in stock near you for practical solutions.